These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9208285)

  • 21. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Anderson JK; Monga M
    J Endourol; 2011 Mar; 25(3):535-40. PubMed ID: 21361824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of dietary calcium and oxalate ratio on urinary stone formation in rats.
    Morozumi M; Ogawa Y
    Mol Urol; 2000; 4(4):313-20. PubMed ID: 11156697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine.
    Thode J; Holgersen RB; Gerstenberg T
    Scand J Clin Lab Invest Suppl; 1993; 214():121-6. PubMed ID: 8332846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic studies during urinary diversion by way of the small intestine].
    Schneider HJ; Bockhorn V
    Z Urol Nephrol; 1979 May; 72(5):365-74. PubMed ID: 39393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is it necessary to systematically reduce dietary calcium intake in lithiasic patients?].
    Fuss M; Van Geel J; Pepersack T; Bergmann P; Van de Walle JC; Simon J
    Acta Urol Belg; 1988; 56(4):511-5. PubMed ID: 3207083
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED; Heller HJ; Adams-Huet B; Brinkley LJ; Pak CY; Pearle MS
    J Urol; 2006 Jul; 176(1):132-6. PubMed ID: 16753387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor.
    Tekin A; Tekgul S; Atsu N; Sahin A; Ozen H; Bakkaloglu M
    J Urol; 2000 Jul; 164(1):162-5. PubMed ID: 10840454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis.
    Pak CY; Peterson R; Poindexter JR
    J Urol; 2001 Feb; 165(2):378-81. PubMed ID: 11176377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The causes and medical treatment of renal calculi.
    Rose GA
    Practitioner; 1977 Jan; 218(1303):74-80. PubMed ID: 13357
    [No Abstract]   [Full Text] [Related]  

  • 37. Substituting milk for apple juice does not increase kidney stone risk in most normocalciuric adults who form calcium oxalate stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 1998 Mar; 98(3):303-8. PubMed ID: 9508013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of calcium calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of calcium stones.
    Parks JH; Coe FL
    Semin Nephrol; 1996 Sep; 16(5):398-411. PubMed ID: 8890396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spherical calcium bodies in stone-forming urine.
    Resnick MI; Boyce WH
    Invest Urol; 1978 May; 15(6):449-51. PubMed ID: 649292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.